SURMOUNT-1: Tirzepatide 15 mg, the generational leap of 2022 SURMOUNT-1 (Jastreboff et al., NEJM 2022, PMID 35658024) randomized 2,539 obese adults without diabetes to tirzepatide 5, 10, or 15 mg/week or placebo over 72 weeks
Finally, we identified six papers describing favorable associations between GLP-related molecules (that is, geniposide, GLP2, puerarin) and reductions in depression-like behavior 170,171,172,173,174,175
Knowing when to reach out to your healthcare provider and when to seek emergency care helps keep you safe and ensures prompt treatment if a serious issue develops
All articles Mounjaro Sulfur Burps Explained: Causes, Symptoms, and Remedies Reading time: 5 min Author Published on Updated on Weight loss Get expert guidance and a personalized care plan designed around you